First Time Loading...
S

Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 17.92 CNY -0.78% Market Closed
Updated: May 4, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

260.3B
+2%
Revenue
Growth Rates:
1 Year
+12%
3 Years
+36%
5 Years
+64%
7 Years
+116%
10 Years
+233%
8.9B
-0.6%
Operating Income
Growth Rates:
1 Year
+7%
3 Years
+14%
5 Years
+55%
7 Years
+137%
10 Years
+215%
3.8B
-18%
Net Income
Growth Rates:
1 Year
-33%
3 Years
-16%
5 Years
-3%
7 Years
+18%
10 Years
+70%

Earnings Waterfall
Shanghai Pharmaceuticals Holding Co Ltd

Revenue
260.3B CNY
Cost of Revenue
-229.3B CNY
Gross Profit
31B CNY
Operating Expenses
-22.2B CNY
Operating Income
8.9B CNY
Other Expenses
-5.1B CNY
Net Income
3.8B CNY

Income Statement
Shanghai Pharmaceuticals Holding Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
78 223
N/A
79 907
+2%
83 518
+5%
88 881
+6%
92 399
+4%
96 250
+4%
99 336
+3%
102 723
+3%
105 517
+3%
109 667
+4%
114 262
+4%
116 994
+2%
120 765
+3%
124 619
+3%
126 848
+2%
129 279
+2%
130 847
+1%
134 104
+2%
140 948
+5%
149 418
+6%
159 084
+6%
168 706
+6%
175 782
+4%
182 101
+4%
186 566
+2%
181 008
-3%
181 156
+0%
186 271
+3%
191 909
+3%
203 061
+6%
209 981
+3%
212 560
+1%
215 824
+2%
221 122
+2%
222 294
+1%
229 463
+3%
231 981
+1%
241 310
+4%
252 866
+5%
254 878
+1%
260 295
+2%
Gross Profit
Cost of Revenue
(68 186)
(69 745)
(73 047)
(77 990)
(81 086)
(84 653)
(87 474)
(90 508)
(92 943)
(96 764)
(100 814)
(103 191)
(106 604)
(110 182)
(111 950)
(113 859)
(114 192)
(116 427)
(121 979)
(128 927)
(136 873)
(145 531)
(151 419)
(157 021)
(160 044)
(155 067)
(155 045)
(159 512)
(164 871)
(175 448)
(181 886)
(184 239)
(187 333)
(193 008)
(193 865)
(200 678)
(201 504)
(210 244)
(221 069)
(223 832)
(229 277)
Gross Profit
10 036
N/A
10 161
+1%
10 471
+3%
10 891
+4%
11 313
+4%
11 597
+3%
11 862
+2%
12 215
+3%
12 573
+3%
12 904
+3%
13 449
+4%
13 803
+3%
14 160
+3%
14 435
+2%
14 896
+3%
15 419
+4%
16 656
+8%
17 677
+6%
18 969
+7%
20 491
+8%
22 211
+8%
23 175
+4%
24 363
+5%
25 079
+3%
26 522
+6%
25 941
-2%
26 111
+1%
26 760
+2%
27 039
+1%
27 613
+2%
28 095
+2%
28 321
+1%
28 492
+1%
28 115
-1%
28 429
+1%
28 785
+1%
30 478
+6%
31 065
+2%
31 797
+2%
31 046
-2%
31 018
0%
Operating Income
Operating Expenses
(7 227)
(7 258)
(7 393)
(7 687)
(8 101)
(8 343)
(8 471)
(8 712)
(8 957)
(9 176)
(9 589)
(9 875)
(10 420)
(10 365)
(10 620)
(10 831)
(11 593)
(12 167)
(13 051)
(13 991)
(16 500)
(17 245)
(18 323)
(19 418)
(19 157)
(19 394)
(19 451)
(19 715)
(19 299)
(18 885)
(19 134)
(19 361)
(20 691)
(20 038)
(20 123)
(20 408)
(22 163)
(22 516)
(23 087)
(22 131)
(22 157)
Selling, General & Administrative
(7 136)
(7 165)
(7 321)
(7 560)
(7 939)
(8 060)
(8 191)
(8 418)
(8 627)
(8 836)
(9 217)
(9 483)
(9 907)
(9 989)
(9 985)
(10 142)
(11 372)
(12 131)
(13 030)
(14 324)
(15 038)
(15 947)
(17 152)
(17 749)
(16 982)
(17 383)
(17 238)
(17 358)
(16 696)
(17 997)
(18 322)
(18 535)
(17 752)
(18 424)
(18 531)
(18 727)
(18 915)
(20 365)
(21 081)
(20 197)
(19 280)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(373)
(503)
0
0
(609)
(756)
(1 005)
(1 332)
(1 146)
(1 165)
(1 267)
(1 420)
(1 462)
(1 529)
(1 540)
(1 730)
(1 860)
(1 984)
(1 828)
(2 020)
(1 917)
(2 010)
(1 940)
(2 205)
(2 329)
(2 191)
(1 999)
Depreciation & Amortization
0
0
0
0
(244)
0
0
0
(285)
0
0
0
(433)
0
0
0
(491)
0
0
0
(745)
0
0
0
(1 364)
0
0
0
(1 571)
0
0
0
(1 535)
0
0
0
(1 557)
0
0
0
(1 557)
Other Operating Expenses
(92)
(92)
(71)
(126)
81
(282)
(279)
(292)
(45)
(340)
(373)
(393)
(79)
(377)
(261)
(186)
270
(36)
587
1 090
288
33
(26)
(506)
455
(591)
(751)
(828)
508
840
1 048
1 158
423
406
325
328
249
55
323
257
679
Operating Income
2 810
N/A
2 904
+3%
3 078
+6%
3 204
+4%
3 212
+0%
3 254
+1%
3 391
+4%
3 503
+3%
3 617
+3%
3 727
+3%
3 859
+4%
3 927
+2%
3 741
-5%
4 071
+9%
4 278
+5%
4 589
+7%
5 062
+10%
5 509
+9%
5 915
+7%
6 498
+10%
5 711
-12%
5 929
+4%
6 040
+2%
5 661
-6%
7 365
+30%
6 546
-11%
6 659
+2%
7 044
+6%
7 740
+10%
8 728
+13%
8 961
+3%
8 960
0%
7 801
-13%
8 076
+4%
8 306
+3%
8 377
+1%
8 315
-1%
8 550
+3%
8 710
+2%
8 915
+2%
8 861
-1%
Pre-Tax Income
Interest Income Expense
230
101
168
111
29
162
38
70
122
86
119
161
471
387
308
133
(85)
(251)
(414)
(470)
(463)
(599)
(421)
(283)
(416)
(464)
(378)
(344)
(118)
(196)
(238)
(512)
(678)
(933)
(1 011)
(830)
(556)
(493)
(1 022)
(1 082)
(1 030)
Non-Reccuring Items
0
0
0
0
29
0
0
0
(52)
0
0
0
174
175
191
227
251
127
113
77
(40)
10
7
13
(735)
64
64
57
(472)
52
59
60
1 074
66
1 480
1 479
1 218
1 453
85
116
(176)
Gain/Loss on Disposition of Assets
0
0
0
(9)
223
0
(17)
(9)
281
202
217
284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
187
182
188
295
307
552
595
521
204
491
433
367
253
59
35
(25)
(23)
(71)
(59)
(78)
135
200
56
202
49
(36)
79
(24)
26
22
7
(12)
(54)
(76)
(90)
(110)
(169)
(196)
(189)
(190)
(600)
Pre-Tax Income
3 227
N/A
3 187
-1%
3 434
+8%
3 601
+5%
3 800
+6%
3 968
+4%
4 006
+1%
4 085
+2%
4 172
+2%
4 506
+8%
4 628
+3%
4 739
+2%
4 639
-2%
4 692
+1%
4 812
+3%
4 924
+2%
5 205
+6%
5 314
+2%
5 555
+5%
6 027
+8%
5 343
-11%
5 540
+4%
5 680
+3%
5 592
-2%
6 262
+12%
6 111
-2%
6 425
+5%
6 733
+5%
7 175
+7%
8 605
+20%
8 788
+2%
8 496
-3%
8 144
-4%
7 133
-12%
8 684
+22%
8 915
+3%
8 808
-1%
9 314
+6%
7 584
-19%
7 759
+2%
7 054
-9%
Net Income
Tax Provision
(628)
(647)
(719)
(742)
(808)
(815)
(775)
(800)
(807)
(880)
(919)
(931)
(809)
(825)
(875)
(921)
(1 147)
(1 204)
(1 250)
(1 138)
(887)
(901)
(928)
(1 048)
(1 432)
(1 427)
(1 463)
(1 589)
(1 570)
(1 851)
(1 901)
(1 886)
(1 869)
(1 704)
(2 010)
(2 020)
(1 816)
(1 901)
(1 739)
(1 798)
(1 888)
Income from Continuing Operations
2 598
2 540
2 716
2 860
2 992
3 154
3 232
3 286
3 364
3 626
3 709
3 808
3 830
3 868
3 937
4 003
4 058
4 109
4 305
4 889
4 456
4 639
4 752
4 544
4 831
4 683
4 961
5 144
5 605
6 755
6 889
6 611
6 275
5 429
6 674
6 895
6 992
7 413
5 845
5 962
5 167
Income to Minority Interest
(383)
(364)
(372)
(382)
(401)
(416)
(425)
(429)
(487)
(594)
(635)
(653)
(633)
(560)
(547)
(575)
(537)
(569)
(677)
(686)
(575)
(652)
(618)
(635)
(750)
(690)
(724)
(860)
(1 109)
(1 177)
(1 267)
(1 233)
(1 181)
(1 205)
(1 453)
(1 472)
(1 375)
(1 529)
(1 313)
(1 362)
(1 399)
Net Income (Common)
2 214
N/A
2 174
-2%
2 342
+8%
2 478
+6%
2 591
+5%
2 739
+6%
2 808
+3%
2 858
+2%
2 877
+1%
3 033
+5%
3 075
+1%
3 155
+3%
3 196
+1%
3 306
+3%
3 389
+3%
3 427
+1%
3 521
+3%
3 541
+1%
3 628
+2%
4 204
+16%
3 881
-8%
3 987
+3%
4 134
+4%
3 908
-5%
4 081
+4%
3 993
-2%
4 238
+6%
4 284
+1%
4 496
+5%
5 578
+24%
5 621
+1%
5 378
-4%
5 093
-5%
4 224
-17%
5 221
+24%
5 423
+4%
5 617
+4%
5 884
+5%
4 531
-23%
4 600
+2%
3 768
-18%
EPS (Diluted)
0.82
N/A
0.81
-1%
0.87
+7%
0.92
+6%
0.96
+4%
1.01
+5%
1.04
+3%
1.06
+2%
1.07
+1%
1.13
+6%
1.14
+1%
1.17
+3%
1.19
+2%
1.22
+3%
1.25
+2%
1.26
+1%
1.31
+4%
1.26
-4%
1.25
-1%
1.47
+18%
1.37
-7%
1.4
+2%
1.46
+4%
1.38
-5%
1.44
+4%
1.41
-2%
1.49
+6%
1.51
+1%
1.58
+5%
1.96
+24%
1.98
+1%
1.89
-5%
1.79
-5%
1.49
-17%
1.41
-5%
1.46
+4%
1.61
+10%
1.6
-1%
1.24
-23%
1.26
+2%
1.02
-19%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.